| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 2e-05 |